baber/WOPTO huggingface dataset:
Patent NZ-598681-A (NZ)
Title: Methods and apparatuses for measuring biological processes using mid-infrared spectroscopy
Inventor: THOMSON ALASDAIR I
IPC: G01N21/35
Filed: 2010-08-30
Abstract: ABSTRACT - 598681 The disclosure relates to a method of measuring biological processes, said method comprising the steps of: directing a mid-infrared signal into an initial sample of a biological process before a biologically active phase; detecting a sample spectrum from the mid-infrared signal to form an initial sample spectrum before the biologically active phase; generating an initial reference spectrum through a reference media comprising water, fermentation material, fiber optic cable, or combinations thereof, before the biologically active phase; combining the initial sample spectrum and the initial reference spectrum to form an adjusted initial sample spectrum; subtracting the adjusted initial sample spectrum from the adjusted sample spectrum to form a difference spectrum; directing the mid-infrared signal into a sample of the biological process during the biologically active phase; detecting a sample spectrum from the mid-infrared signal to form a sample spectrum; generating a reference spectrum through the reference media; and combining the sample spectrum and the reference spectrum to form an adjusted sample spectrum, wherein the mid-infrared signal comprises wave numbers of between about 4,000 centimeters-1 to about 400 centimeters-1, and the mid-infrared signal penetrates into the sample between about 1 micron and about 10 microns.
Patent NZ-598845-A (NZ)
Title: Recording and reading data on a multi-layer optical disc including with two sources of radiation with different wavelengths
Inventor: KIYKO VADIM VENIAMINOVICH
IPC: G11B7/002
Filed: 2010-09-09
Abstract: 598845 Disclosed is a device for recording/reading information on a multilayer optical disc (1). The device includes an optical disc positioning system (6), a source of radiation (3) with wavelength ?1, a source of radiation (5) with wavelength ?2 and a focusing system (4) that is arranged such that its optical axis is perpendicular to the flat surface of the multilayer optical disc (1) and is within a focusing system positioning means. An illumination system is arranged such that its optical axis is perpendicular to the optical axis of the focusing system (4). A spectrum splitter (14) is located between the source of radiation with wavelength ?1 and the focusing system (4), as well as an optical sensor (8) optically coupled with the focusing system (4) via the spectrum splitter (14). Also included is a control unit (9) electrically coupled with the sources of radiation (3, 5) with wavelengths ?1 and ?2, and the optical sensor (8). The source of radiation (5) with wavelength ?2 is designed as a strip of laser diodes whose optical axes are parallel and lie in the same plane, while the illumination system has components serially arranged along the optical axis. The components include a cylindrical lens (11) which is arranged such that the generatrix of its cylindrical surface is parallel to the plane in which the p-n junctions of the laser diodes are located, a focusing lens and a stabilizing circuit that includes a beam splitter that is placed between the focusing lens (15) and the cylindrical lens (11). A second optical sensor is optically coupled with the focusing lens (15) via the beam splitter (14), and a stabilizer is coupled with the focusing lens (15). The stabilizer and second optical sensor are electrically connected to the control unit.
Patent NZ-609448-A (NZ)
Title: Tricyclic pi3k inhibitor compounds and methods of use
Inventor: DOTSON JENNAFER
IPC: C07D498/14
Filed: 2011-12-15
Abstract: The disclosure relates to morpholino-oxazino-purin-pyrimidin-2-amine derivatives of formula (I) having anti-cancer activity, anti-inflammatory activity, or immunoregulatory properties, and more specifically with PI3 kinase modulating or inhibitory activity, wherein the variables shown in formula (I) are as defined in the specification. Methods are described for using these tricyclic PI3K inhibitor compounds of formula (I) for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, organisms, or associated pathological conditions. These tricyclic compounds include stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts thereof. Exemplary compounds include: 5-(6,6-dimethyl-4-morpholino-8,9-dihydro-6h-[1,4]oxazino[3,4-e]purin-2-yl)pyrimidin-2-amine and 5-(6,6-dimethyl-4-morpholino-8,9-dihydro-6h-[1,4]oxazino[3,4-e]purin-2-yl)-4-(trifluoromethyl)pyridyl-2-amine.
Patent NZ-619447-A (NZ)
Title: Glucagon/glp-1 receptor co-agonists
Inventor: DIMARCHI RICHARD D
IPC: A61P3/10
Filed: 2012-06-12
Abstract: Disclosed is a peptide comprising or consisting of the amino acid sequence of HXQGTFTSDKSKYLDXRAAQDFVQWLMNTKX or a pharmaceutically acceptable salt thereof. Also disclosed is the use of such a peptide in the manufacture of a medicament for the treatment of a disease or medical condition selected from the group consisting of: metabolic syndrome, diabetes, obesity, liver steatosis, and a neurodegenerative disease.
Patent NZ-619460-A (NZ)
Title: Methods and apparatus for an embedded appliance
Inventor: SMITH JOHN J
IPC: H04N11/24
Filed: 2012-06-29
Abstract: An apparatus comprises a media module (430A, 430B) and a modification module included in an embedded appliance is disclosed. The media module (430A, 430B) is configured to receive a first media signal associated with a first input port of the embedded appliance and a second media signal associated with a second input port of the embedded appliance. The media module (430A, 430B) is configured to identify a first set of media signal parameters based on the first media signal. The modification module is configured to receive a modification instruction associated with a session format having a second set of media signal parameters different from the first set. The modification module is configured to modify the first media signal based on the first set of media signal parameters and the modification instruction to produce a first modified media signal in the session format and having the second set of media signal parameters. The media module (430A, 430B) configured to identify, at a second time after the first time, a third plurality of media signal parameters different from the first plurality of media signal parameters and based on the first media signal. The modification module configured to receive a second modification instruction associated with the session format. The modification module configured to modify the first media signal based on the third plurality of media signal parameters and the second modification instruction to produce a second modified media signal in the session format and having the second plurality of media signal parameters.
Patent NZ-622337-A (NZ)
Title: Screwdriver tool with improved corner fit function
Inventor: DESMOND MICHAEL R
IPC: B25B23/06
Filed: 2012-10-31
Abstract: An automatic fastener driving tool, or an attachment, has a narrow front-end profile so that it is capable of driving screws that are in hard-to-reach positions, such as corners or channel members. The slide body subassembly has an extending mechanism, so that the fastener drive elements extend farther away from the main body structure of the tool/attachment, while still providing a stable and rugged overall tool structure to drive larger screws. The “lick-out” dimension is increased without also increasing the length and width of the feed tube.
Patent NZ-702680-A (NZ)
Title: Anti-gd2 antibodies
Inventor: AHMED MAHIUDDIN
IPC: C12N5/07
Filed: 2011-06-20
Abstract: Disclosed is a chimeric antibody or fragment thereof capable of binding to GD2, wherein said chimeric antibody or fragment thereof comprises a variable heavy chain domain and a variable light chain domain as defined in the complete specification.
Patent NZ-703786-A (NZ)
Title: Fgfr1 extracellular domain combination therapies
Inventor: LONG LI
IPC: C07K19/00
Filed: 2011-11-14
Abstract: Disclosed is the use of a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) fusion molecule and at least one additional therapeutic agent selected from paclitaxel, carboplatin, oxaliplatin, doxorubicin, pemetrexed, etoposide, and a VEGF trap, for the manufacture of a medicament for treating cancer in a subject, wherein the medicament is formulated for administration of an effective amount of the FGFR1 ECD fusion molecule and the at least one additional therapeutic agent to the subject, and wherein administration of the FGFR1 ECD fusion molecule comprises an FGFR1 ECD comprising an amino acid sequence selected from SEQ ID NOs: 1 to 4 and a fusion partner, wherein administration of the FGFR1 ECD fusion molecule and the at least one additional therapeutic agent results in at least additive inhibition of tumour growth in a mouse xenograft model of the cancer, and wherein the sequences are as disclosed in the complete specification.
Patent NZ-705890-A (NZ)
Title: Drenching platform or system, consumables thereof and related aspects
Inventor: CLEVERLY DOUGLAS ROBERT
IPC: A61P33/10
Filed: 2009-09-07
Abstract: The disclosure relates to anthelmintic compositions in the form of a stable granule comprising: (a) levamisole HCL; (b) an anthelmintic active selected from (i) one or more imidazothiazoles, (ii) one or more benzimidazoles selected from oxfendazole, albendazole or fenbendazole, (iii) one or more macrocyclic lactones selected from avermectin, ivermectin and abamectin, and (iv) praziquantel; (c) a wetting agent; and (d) a suspending agent if the anthelmintic actives comprise a benzimidazole or praziquantel; and the stable granule being readily dispersible in water to provide a homogenous mixture of the anthelmintic actives for administration to a non-human mammal.
Patent NZ-714708-A (NZ)
Title: Method for preventing and/or treating chronic traumatic encephalopathy-ii
Inventor: VINK ROBERT
IPC: A61P25/00
Filed: 2014-07-02
Abstract: The present invention relates to a method of preventing and/or treating chronic traumatic encephalopathy by administering to a subject N-(3,5-Bis-trifluoromethyl-benzyl)-N-methyl-6-(piperazin-1-yl)-4-o-tolyl nicotinamide or 4-alkyl-piperazin-1-yl derivatives thereof as represented by formula (I) below:
Patent NZ-715324-A (NZ)
Title: Cargo transfer vessel
Inventor: SYVERTSEN KÅRE
IPC: B63B39/06
Filed: 2014-06-23
Abstract: Loading of fluid to tankers in open sea may be a demanding operation. The operation requires dedicated shuttle tankers equipped with dynamic positioning system, excessive thruster capacity and specialized loading systems. One such system for loading tankers in exposed and harsh environments is Submerged Turret Loading. Typically, there are dedicated ships with specially designed equipment for such systems, resulting in higher investment compared with conventional tankers. In more benign environments, offshore loading with conventional tankers can be performed using moored floating buoys. However, this system is limited by the sea state, current and wind. In addition, conventional tankers have limited maneuvering and station keeping capabilities. There is a need to mitigate the disadvantages with existing systems and to further reduce the investments in extra equipment. The present invention provides a method and a system that further improves the loading efficiency of conventional tankers, LNG carriers or other ships carrying fluids in open sea. The cargo transfer vessel comprises a hull having a first and a second outer longitudinal hull side; a transfer vessel deck, propulsion means for actively maintaining the cargo transfer vessel at a predetermined distance from the offshore production facility and the tanker during fluid transfer operations and fluid transfer means for transferring fluid between the offshore structure and the tanker. The vessel is further characterized in that the hull comprises a main hull member and at least one protruding hull member arranged below the cargo transfer vessel’s water line at each of the outer longitudinal hull sides for suppressing roll of the vessel, wherein the at least one protruding hull member extends at least partly along the hull’s longitudinal length, wherein one or both of the ends of the at least one protruding hull member have an inclination angle exceeding 10 degrees relative to a horizontal plane, and wherein said fluid transfer means comprises a side loading arrangement for receiving fluid from the offshore production facility comprising at least one loading manifold positioned at a side of the transfer vessel and configured to be connected to an end of at least one production facility loading hose.
Patent NZ-721281-A (NZ)
Title: Spread spectrum signal generating method, generating apparatus, receiving method and receiving apparatus
Inventor: YAO ZHENG
IPC: H04B1/707
Filed: 2014-12-04
Abstract: This application provides a spread spectrum signal generating method, generating apparatus, receiving method and receiving apparatus. The spread spectrum signal generating method comprises generating a first spread spectrum signal component and a second spread spectrum signal component, wherein either of the first spread spectrum signal component and the second spread spectrum signal component comprises a spread spectrum code and binary sub-carrier, the spread spectrum codes of the first spread spectrum signal component and the second spread spectrum signal component are the same, and the binary sub-carriers of the first spread spectrum signal component and the second spread spectrum signal component are different; and modulating the first spread spectrum signal component and the second spread spectrum signal component to radio frequency carriers to generate spread spectrum signals, wherein a phase of the radio frequency carrier of the modulated first spread spectrum signal component and a phase of the radio frequency carrier of the modulated second spread spectrum signal component are different.
Patent NZ-727479-A (NZ)
Title: Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy
Inventor: MAEURER MARKUS
IPC: A61K38/20
Filed: 2015-06-11
Abstract: The present invention relates to a composition for expanding lymphocytes comprising interleukin 2 (IL-2), interleukin 15 (IL-15) and interleukin 21 (IL-21). It further relates to a method of preparing a population of clinically relevant lymphocytes, comprising the steps of: providing a previously obtained body sample from a mammal in particular a tissue sample or body liquid sample, comprising at least one lymphocyte and optionally separating the cells in the body sample, culturing the body sample in-vitro to expand and/or stimulate lymphocytes in the sample wherein the culturing comprises using IL-2, IL-15 and IL-21, and optionally determining the presence of clinically relevant lymphocyte in the cultured sample. The present invention also relates to an immunotherapy and the population of clinically relevant lymphocytes.
Patent NZ-731150-A (NZ)
Title: A coin deposit and dispensing machine and a method for controlling output of coins from a coin deposit and dispensing machine
Inventor: Håkan Melin
IPC: G07D3/16
Filed: 2017-04-19
Abstract: A coin depositing and dispensing machine (100) comprises: a front face (102); a coin input unit (104); a coin processing unit (106); at least one container (110) for storing coins of a specific denomination; and a coin output unit (120), comprising a first element (122) and a second element (124) carrying the first element (122), wherein the first element (122) in a first position (122A) is arranged relative the at least one container (110) for receiving coins from the at least one container (110), wherein the first element (122) is displaceable relative the second element (124) from the first position (122A) towards the front face (102) to a second position (122B), and wherein the second element (124), when the first element (122) is in the second position (122B), is displaceable for carrying the first element (122) to an output position (122C), where the first element (122) at least partially protrudes from the front face (102).
Patent NZ-741109-A (NZ)
Title: Carrier arm assembly
Inventor: NIELSEN RASMUS ELMELUND
IPC: A01D34/86
Filed: 2016-09-26
Abstract: A carrier arm assembly for an operating unit of an agricultural machine includes a carrier arm having a base part and an extending part that is telescopically adjustable relative to the base part to adjust the length of the carrier arm between an unextended configuration and an extended configuration. The base part and the extending part both include a set of bearing surfaces that are configured to enable sliding movement of the extending part relative to the base part. The bearing surfaces of the base part include upper inclined bearing surfaces and lower inclined bearing surfaces, and the bearing surfaces of the extending part include upper inclined bearing surfaces and lower inclined bearing surfaces, which are configured to engage respectively the upper inclined bearing surfaces and the lower inclined bearing surfaces of the base part.
Patent NZ-752677-A (NZ)
Title: Analysis system and method for testing a sample
Inventor: SCHMOLKE HANNAH
IPC: G01N35/00
Filed: 2017-10-05
Abstract: The present disclosure is concerned with the field of bioanalytics. Described systems and methods concern, in particular, testing a sample by means of an analysis system. The prob-lem addressed by the present embodiments is to provide a system for testing a sample, such as a biological sample, in a more efficient, individual and/or flexible manner. The claimed solution involves using an analysis system for testing a sample. The analysis sys-tem comprises a cartridge for receiving the sample, an analysis device for receiving the cartridge and subsequently carrying out the test using the received cartridge, and an oper-ating instrument which is separable from the analysis device with respect to a data connec-tion and/or which is wirelessly connectable to the analysis device. The operating instru-ment is designed to determine or read out a cartridge identifier corresponding to the car-tridge and, using this cartridge identifier, to retrieve from a database control information for carrying out the test and to transmit the control information to the analysis device. The analysis device is configured for carrying out the testing using the control information transmitted independently, disconnectedly, and/or separately from the operating instru-ment.
Patent NZ-761095-A (NZ)
Title: Composition for debitterizing hydrolyzed proteins and product, preparation and uses thereof
Inventor: LIU BIAO
IPC: A23L5/20
Filed: 2018-10-11
Abstract: A hydrolysed protein debittering composition and the product, preparation, and application thereof, the composition comprising short chain fatty acids, medium chain fatty acids, and long chain fatty acids; based on the total mass of the short chain fatty acids, medium chain fatty acids, and long chain fatty acids being 100%, the content of the medium chain fatty acids is 0.2-4.7%, the content of the long chain fatty acids is 95.1-99.4%, and the remainder is short chain fatty acids. The present hydrolysed protein debittering composition can be used for preparing infant formula milk powder, milk powder for the elderly, and other infant formula food for special medical uses.
Patent NZ-761329-A (NZ)
Title: Non-human animals comprising a humanized ttr locus and methods of use
Inventor: FRENDEWEY DAVID
IPC: A01K67/027
Filed: 2018-09-28
Abstract: Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized TTR locus and methods of using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized TTR locus express a human transthyretin protein or a chimeric transthyretin protein, fragments of which are from human transthyretin. Methods are provided for using such non-human animals comprising a humanized TTR locus to assess in vivo efficacy of human-TTR-targeting reagents such as nuclease agents designed to target human TTR. Methods are also provided for making such non-human animals comprising a humanized TTR locus.
Patent NZ-770592-A (NZ)
Title: Eddy current brake configurations
Inventor: ALLINGTON CHRISTOPHER JAMES
IPC: F16D63/00
Filed: 2014-12-04
Abstract: Described herein are eddy current brake configurations and methods of use, particularly configurations that have a kinematic relationship with at least two rotational degrees of freedom used to tune operation of the brake or apparatus in which the brake is located.
Patent NZ-793413-A (NZ)
Title: Outcoupling grating for augmented reality system
Inventor: TEKOLSTE ROBERT
IPC: G02B6/00
Filed: 2017-10-25
Abstract: Disclosed is an eyepiece for use in front of an eye of a viewer. The eyepiece comprising a waveguide having a surface, and a diffractive optical element optically coupled to the waveguide. The diffractive optical element including a plurality of first ridges protruding from the surface of the waveguide and arranged as a periodic array having a period. Each of the plurality of first ridges having a first height in a direction perpendicular to the surface of the waveguide and a first width in a direction of the period, and a plurality of second ridges. Each of the plurality of second ridges protruding from a respective first ridge and having a second height greater than the first height and a second width less than the first width. The diffractive optical element is configured to diffract a portion of a first light beam incident on the diffractive optical element toward the eye as a first order transmission. The first width and the second width are selected such that the diffractive optical element has a first order reflection efficiency greater than a first order transmission efficiency.
Patent NZ-798427-A (NZ)
Title: Infill for artificial turf system
Inventor: KEYSER STEPHEN
IPC: D05C15/08
Filed: 2018-03-29
Abstract: An infill material (24) for an artificial turf system having a plurality of wood particles (24B), each particle defining a length dimension greater than a width or a thickness dimension, with the length and width or thickness defining an aspect ratio of up to 10:1. The length of each particle is oriented generally parallel to a grain structure of each particle, with the length ranging from 0.5mm to about 10mm. The wood particles have a generally rounded edge. Each particle can absorb and release water, allowing the dispersal of heat from the infill material. The use of synthetic materials such as rubber and thermoplastics in artificial turf systems leads to turf heat retention problems, necessitating the use of complex cooling systems. Additionally, the disposal of synthetic infill materials is increasingly costly and problematic. The invention provides a wood-based infill material that naturally incorporates cooling based on the water absorptive properties of wood particles.